MedKoo Cat#: 574587 | Name: BIBU-1361 HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BIBU-1361 is an EGFR inhibitor. BIBU1361 blocked epidermal growth factor-induced phosphorylation of EGFR and also prevented downstream responses such as mitogen-activated protein kinase kinase (MAPK/extracellular signal-regulated kinase kinase) and MAPK activation in cells. In accordance with these observations thymidine incorporation into EGFR-expressing KB cells was selectively and potently inhibited by BIBU1361 with half-maximally effective doses in the nanomolar range. Oral administration of BIBU-1361 inhibited the growth of established human xenografts in athymic mice, including vulval and head and neck squamous cell carcinomas.

Chemical Structure

BIBU-1361 HCl
BIBU-1361 HCl
CAS#1643609-75-9 (HCl)

Theoretical Analysis

MedKoo Cat#: 574587

Name: BIBU-1361 HCl

CAS#: 1643609-75-9 (HCl)

Chemical Formula: C22H29Cl3FN7

Exact Mass: 515.1534

Molecular Weight: 516.87

Elemental Analysis: C, 51.12; H, 5.66; Cl, 20.58; F, 3.68; N, 18.97

Price and Availability

Size Price Availability Quantity
Bulk Inquiry
Buy Now
Add to Cart
Synonym
BIBU-1361 dihydrochloride, BIBU-1361 2HCl; BIBU-1361; BIBU 1361; BIBU1361;
IUPAC/Chemical Name
N-(3-Chloro-4-fluorophenyl)-6-[4-[(diethylamino)methyl]-1-piperidinyl]-pyrimido[5,4-d]pyrimidin-4-amine dihydrochloride
InChi Key
ZNNWCQCQUKAMGL-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H27ClFN7.2ClH/c1-3-30(4-2)13-15-7-9-31(10-8-15)22-25-12-19-20(29-22)21(27-14-26-19)28-16-5-6-18(24)17(23)11-16;;/h5-6,11-12,14-15H,3-4,7-10,13H2,1-2H3,(H,26,27,28);2*1H
SMILES Code
CCN(CC1CCN(C2=NC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=N2)CC1)CC.[H]Cl.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Selective inhibitor of EGFR-kinase.
In vitro activity:
BIBU (BIBU-1361) caused increased LC3-I to LC3-II conversion and triggered the internalization of EGFR within vacuoles along with its increased co-localization with LC3-II. BIBU caused accumulation of p62 and increased levels of cleaved forms of Beclin-1 in all the cell lines tested. Reference: Mol Carcinog. 2013 Dec;52(12):970-82. https://pubmed.ncbi.nlm.nih.gov/22753156/
In vivo activity:
Treatment with BIBU1361 (Fig. 2a) showed that the lower concentration 0.1 mg/ml induced β-Galactosidase expression first in the intestinal cells of adult PC72 C. elegans (Fig. 2b). At higher concentrations (e.g., 0.4 mg/ml BIBU1361), a strong expression of β-Galactosidase was observed in cells of the head–pharynx region and the midbody region (Fig. 2c). No nematodes survived after exposure to 0.5 mg/ml BIBU1361. Reference: J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):209-14. https://pubmed.ncbi.nlm.nih.gov/15519907/
Solvent mg/mL mM comments
Solubility
DMSO 12.9 25.00
Water 51.7 100.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 516.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Ghildiyal R, Dixit D, Sen E. EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells. Mol Carcinog. 2013 Dec;52(12):970-82. doi: 10.1002/mc.21938. Epub 2012 Jun 29. PMID: 22753156. 2. Dengg M, van Meel JC. Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds. J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):209-14. doi: 10.1016/j.vascn.2004.04.002. PMID: 15519907.
In vitro protocol:
1. Ghildiyal R, Dixit D, Sen E. EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells. Mol Carcinog. 2013 Dec;52(12):970-82. doi: 10.1002/mc.21938. Epub 2012 Jun 29. PMID: 22753156.
In vivo protocol:
1. Dengg M, van Meel JC. Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds. J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):209-14. doi: 10.1016/j.vascn.2004.04.002. PMID: 15519907.
1: Ghildiyal R, Dixit D, Sen E. EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells. Mol Carcinog. 2013 Dec;52(12):970-82. doi: 10.1002/mc.21938. Epub 2012 Jun 29. PMID: 22753156. 2: Dengg M, van Meel JC. Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds. J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):209-14. doi: 10.1016/j.vascn.2004.04.002. PMID: 15519907. 3: Solca FF, Baum A, Langkopf E, Dahmann G, Heider KH, Himmelsbach F, van Meel JC. Inhibition of epidermal growth factor receptor activity by two pyrimidopyrimidine derivatives. J Pharmacol Exp Ther. 2004 Nov;311(2):502-9. doi: 10.1124/jpet.104.069138. Epub 2004 Jun 15. PMID: 15199094.